Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
STXS
#3745
Stereotaxis, Inc. Common Stock
1.969
9
USD
-1.51%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.51%
Monthly Change
+1.55%
6 month change
-5.29%
Year Change
-5.29%
Previous Close
2.000
0
Open
1.968
0
Bid
Ask
Low
1.955
0
High
1.980
0
Volume
60
Markets
US Stock Market
Healthcare
STXS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Cash from operating activities
1.27 M
-1.78 M
-3.73 M
-4.2 M
-3.97 M
-13.69 M
Cash from investing activities
-2 000
0
23 K
0
-70 K
-47 K
Cash from financing activities
159 K
32 K
34 K
7.74 M
6.95 M
14.76 M
Free cash flow
1.26 M
-1.78 M
-3.76 M
-4.2 M
-4.04 M
-13.78 M
News
Stereotaxis, Inc. (STXS) M&A Call Transcript
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis earnings matched, revenue fell short of estimates
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates
FDA grants additional 3-year exclusivity for Shield’s ACCRUFeR
Shield Therapeutics expects ACCRUFeR approval in China by Q1 2026